The Loss and OCD Symptoms Scale is a newly validated tool designed to assess grief and loss among adults with OCD.

A new agreement between the VA and HHS aims to accelerate clinical research and deployment of psychedelic therapies for veterans with mental illness.

Mirtazapine should be used selectively in older inpatients, as it fails to significantly improve appetite or weight.

Evaluating suicidal ideation with smartphone ecological momentary assessment reveals a need for clearly defined constructs and stronger validation.

Treatments for fibrodysplasia ossificans progressiva, gastroenteropancreatic neuroendocrine tumors, HIV, influenza, and multiple myeloma are under review.

Researchers identified shared genetic loci and pathogenic mechanisms linking inflammatory bowel disease with several ...

Task-sharing mental health care with non-specialist providers benefits adults with psychologic distress after experiencing violence.

The Food and Drug Administration (FDA) has granted Fast Track designation to remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer disease psychosis (ADP).

Challenging patient interactions can be an adverse influence on the emotions and stress level of emergency physicians.

Blood-based biomarkers can help improve accuracy when diagnosing Alzheimer disease and related cognitive impairment or dementia.

An in vivo assessment tool measuring negative emotion reactivity may predict future self-harm and suicidal ideation in adolescents.